Table 2

HU values showing 11 time-points on the TDC of peripheral lung cancer, inflammatory nodule, and benign nodule

Pathologic type
2 S
6 S
10 S
14 S
18 S
22 S
26 S
30 S
34 S
38 S
42 S

Peripheral lung
11.46
21.66
29.94
36.05
40.76
48.86
51.77
50.16
45.81
43.55
42.16
Cancer
±4.41
±6.71
±7.99
±9.54
±10.64
±10.75
±10.21
±10.50
±9.67
±10.02
±9.54
Inflammatory
18.55
35.60
40.86
43.96
50.60
56.97
63.64
60.57
49.52
43.98
42.02
Nodule
±6.60
±7.59
±7.47
±8.05
±8.17
±6.37
±6.97
±8.11
±7.56
±8.41
±8.18
Benign nodule
5.68
9.39
12.14
16.41
17.73
19.08
21.84
20.97
20.28
19.68
18.73

±5.25
±8.94
±8.82
±7.13
±5.83
±9.16
±13.28
±12.47
±10.84
±11.11
±10.46

*Data is the mean ± SD.

Ma et al. BMC Cancer 2008 8:186   doi:10.1186/1471-2407-8-186